Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gastroesophageal reflux disease: From heartburn to cancer.

Literature DB >> 20698034

Gastroesophageal reflux disease: From heartburn to cancer.

Abstract

About 10%-15% of patients with gastroesophageal reflux disease develop Barrett's esophagus. This is considered a premalignant condition because it can progress from metaplasia to high-grade dysplasia, and eventually to adenocarcinoma. Recently, major advances have been made in the endoscopic treatment of Barrett's esophagus, therefore limiting the role of surgery in the treatment of this disease.

Entities: Disease Species

Mesh：

Year: 2010 PMID： 20698034 PMCID： PMC2921083 DOI： 10.3748/wjg.v16.i30.3743

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

24 in total

1. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.

Authors: John D Urschel; Hari Vasan; Chris J Blewett
Journal: Am J Surg Date: 2002-03 Impact factor: 2.565

2. Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?

Authors: Richard Greil; Hubert J Stein
Journal: Lancet Oncol Date: 2007-03 Impact factor: 41.316

3. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology?

Authors: A T Prach; T A MacDonald; D A Hopwood; D A Johnston
Journal: Lancet Date: 1997-09-27 Impact factor: 79.321

4. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors: Heiko Pohl; H Gilbert Welch
Journal: J Natl Cancer Inst Date: 2005-01-19 Impact factor: 13.506

5. The burden of selected digestive diseases in the United States.

Authors: Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin
Journal: Gastroenterology Date: 2002-05 Impact factor: 22.682

6. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology.

Authors: Anand P Tamhankar; Jeffrey H Peters; Giussepe Portale; Chih-Cheng Hsieh; Jeffrey A Hagen; Cedric G Bremner; Tom R DeMeester
Journal: J Gastrointest Surg Date: 2004-11 Impact factor: 3.452

Review 7. Minimally invasive esophagectomy for cancer.

Authors: Georges Decker; Willy Coosemans; Paul De Leyn; Herbert Decaluwé; Philippe Nafteux; Dirk Van Raemdonck; Toni Lerut
Journal: Eur J Cardiothorac Surg Date: 2008-10-25 Impact factor: 4.191

8. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.

Authors: Robert A Ganz; Bergein F Overholt; Virender K Sharma; David E Fleischer; Nicholas J Shaheen; Charles J Lightdale; Stephen R Freeman; Ronald E Pruitt; Shiro M Urayama; Frank Gress; Darren A Pavey; M Stanley Branch; Thomas J Savides; Kenneth J Chang; V Raman Muthusamy; Anthony G Bohorfoush; Samuel C Pace; Steven R DeMeester; Viktor E Eysselein; Masoud Panjehpour; George Triadafilopoulos
Journal: Gastrointest Endosc Date: 2008-03-19 Impact factor: 9.427

9. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.

Authors: Jikke M T Omloo; Sjoerd M Lagarde; Jan B F Hulscher; Johannes B Reitsma; Paul Fockens; Herman van Dekken; Fiebo J W Ten Kate; Huug Obertop; Hugo W Tilanus; J Jan B van Lanschot
Journal: Ann Surg Date: 2007-12 Impact factor: 12.969